SHANGHAI, Aug. 4, 2025 /PRNewswire/ — Aphranel, China’s leading innovator of regenerative aesthetics medicine, recently made waves at IMCAS China 2025 with its 36㎡ platinum sponsorship booth, hosted a 60-minute scientific symposium and 30-minute live-case with its breakthrough product Aphranel® MagiCCrystal CaHA Filler.
IMCAS leadership including Congress Chair Prof. Cui Haiyan, IMCAS Paris Chairmen Dr. Cartier and Dr. Garson visited Aphranel, recognizing its significant contributions to global industry of regenerative aesthetics medicine. This high-profile exhibiting in IMCAS China, demonstrated the Aphranel’s growing influence on the advanced anti-aging solutions in the global market.
About Aphranel
Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.
ข่าวที่เกี่ยวข้อง
- Sunway Medical Centre Penang Receives Dual Honours at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition for Healthcare Excellence and Brand Leadership
- เผยโฉมผู้สร้างการเปลี่ยนแปลงทางวัฒนธรรมและไอคอนวงการอาหาร ร่วมเป็นคณะกรรมการตัดสินระดับโลก ประจำการแข่งขัน S.Pellegrino Young Chef Academy Competition ประจำปี 2569-2570
- Ph fintech Mynt scales GStocks into country’s largest online retail platform for local stock market
- Simple Recycle Company Limited Recognized for Building a Digitally Enabled Circular Ecosystem in Thailand
